SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011056
Filing Date
2017-05-15
Accepted
2017-05-15 16:45:32
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20170331.htm 10-Q 1317274
2 EX-10.2 kura-ex102_452.htm EX-10.2 70129
3 EX-31.1 kura-ex311_8.htm EX-31.1 17186
4 EX-31.2 kura-ex312_7.htm EX-31.2 16952
5 EX-32.1 kura-ex321_6.htm EX-32.1 9616
  Complete submission text file 0001564590-17-011056.txt   4436177

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kura-20170331.xml EX-101.INS 956056
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20170331.xsd EX-101.SCH 31119
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20170331_cal.xml EX-101.CAL 39065
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20170331_def.xml EX-101.DEF 78684
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20170331_lab.xml EX-101.LAB 229852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20170331_pre.xml EX-101.PRE 162672
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 17845058
SIC: 2834 Pharmaceutical Preparations